All In Biotech

Drug Trial Radar · NCT05630573

A Study of TNM001 in Chinese Healthy Preterm and Term Infants

A Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-escalation Phase Ib/IIa Study to Evaluate the Safety, Tolerability, and Pharmacokinetic Profile of TNM001 Injection in Chinese Healthy Preterm and Term Infants

Last checked: Nov 19, 2026Latest source record: Jun 28, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

31

Actual

Start

Oct 25, 2022

Primary completion

Jun 30, 2023

Study completion Jun 30, 2023

Sponsor

Sponsor type
Industry
First posted
Nov 29, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Randomized
Model
Sequential
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
Yes
Who can join
All sexes, up to 1 year
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this clinical trial is to evaluate the safety, tolerability and pharmacokinetics (PK) profile of TNM001 injection in healthy preterm and term infants. The main questions it aims to answer are: * the safety and tolerability of TNM001 injection * the pharmacokinetic (PK) profile of TNM001

Conditions

  • Respiratory Syncytial Virus Infections

Interventions

  • TNM001Biological

    intramuscular injection

  • PlaceboBiological

    intramuscular injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety and tolerability of TNM001 InjectionTime frame: 150 days post dose

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • The Second Hospital of Hebei Medical University

    Shijiazhuang, Hebei, China

  • Hunan Provincial People's Hospital

    Changsha, Hunan, China

  • The Third Xiangya Hospital of Central South University

    Changsha, Hunan, China

  • Linfen People's Hospital

    Linfen, Shanxi, China

  • Yuncheng Central Hospital

    Yuncheng, Shanxi, China

  • West China Second University Hospital, Sichuan University

    Chengdu, Sichuan, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.